Suppr超能文献

一类新型的N-甲基-D-天冬氨酸受体功能负性变构调节剂。

A novel class of negative allosteric modulators of NMDA receptor function.

作者信息

Katzman Brooke M, Perszyk Riley E, Yuan Hongjie, Tahirovic Yesim Altas, Sotimehin Ayodeji E, Traynelis Stephen F, Liotta Dennis C

机构信息

Department of Chemistry, Emory University, 1521 Dickey Drive, Atlanta, GA 30322, United States.

Department of Pharmacology, Emory University School of Medicine, 1510 Clifton Road, Atlanta, GA 30322, United States.

出版信息

Bioorg Med Chem Lett. 2015 Dec 1;25(23):5583-8. doi: 10.1016/j.bmcl.2015.10.046. Epub 2015 Oct 19.

Abstract

NMDA receptors mediate a slow Ca(2+)-permeable component of excitatory synaptic transmission, and are involved in numerous normal brain functions including learning and memory. NMDA receptor over-activation can lead to cell death and abnormal excitation in ischemia associated with stroke, traumatic brain injury, and epilepsy. We have explored a series of novel noncompetitive allosteric modulators of NMDA receptor function characterized by an iminothiazolidinone ring. Saturating concentrations of these compounds inhibit NMDA receptors to varying maximal extents, raising the possibility that they may attenuate over-activation in pathological situations while preserving some minimal receptor function, which may limit side-effects. The best in class compounds have sub-micromolar IC50 values and show modest preference for GluN2C- and GluN2D-containing receptors.

摘要

NMDA受体介导兴奋性突触传递中缓慢的钙离子通透成分,并参与包括学习和记忆在内的多种正常脑功能。NMDA受体过度激活可导致与中风、创伤性脑损伤和癫痫相关的缺血中的细胞死亡和异常兴奋。我们探索了一系列以亚氨基噻唑烷酮环为特征的新型NMDA受体功能非竞争性变构调节剂。这些化合物的饱和浓度在不同程度上抑制NMDA受体,这增加了它们在病理情况下可能减弱过度激活同时保留一些最小受体功能的可能性,这可能会限制副作用。同类最佳的化合物具有亚微摩尔的IC50值,并且对含GluN2C和GluN2D的受体表现出适度的偏好。

相似文献

1
A novel class of negative allosteric modulators of NMDA receptor function.
Bioorg Med Chem Lett. 2015 Dec 1;25(23):5583-8. doi: 10.1016/j.bmcl.2015.10.046. Epub 2015 Oct 19.
3
A novel family of negative and positive allosteric modulators of NMDA receptors.
J Pharmacol Exp Ther. 2010 Dec;335(3):614-21. doi: 10.1124/jpet.110.174144. Epub 2010 Sep 21.
6
PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunits.
Neuropharmacology. 2020 Aug 15;173:107971. doi: 10.1016/j.neuropharm.2020.107971. Epub 2020 Jan 25.
8
Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of -Methyl-d-aspartate Receptors.
ACS Chem Neurosci. 2021 Jan 6;12(1):79-98. doi: 10.1021/acschemneuro.0c00561. Epub 2020 Dec 16.
9
Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator.
Mol Pharmacol. 2014 Nov;86(5):548-60. doi: 10.1124/mol.114.094516. Epub 2014 Sep 9.
10
The Bioactive Protein-Ligand Conformation of GluN2C-Selective Positive Allosteric Modulators Bound to the NMDA Receptor.
Mol Pharmacol. 2018 Feb;93(2):141-156. doi: 10.1124/mol.117.110940. Epub 2017 Dec 14.

引用本文的文献

1
Reduction of the Ca permeability of ligand-gated ion channels as a strategy against excitotoxicity.
Front Cell Neurosci. 2025 Jul 16;19:1617006. doi: 10.3389/fncel.2025.1617006. eCollection 2025.
3
Development of a Dihydroquinoline-Pyrazoline GluN2C/2D-Selective Negative Allosteric Modulator of the -Methyl-d-aspartate Receptor.
ACS Chem Neurosci. 2023 Sep 6;14(17):3059-3076. doi: 10.1021/acschemneuro.3c00181. Epub 2023 Aug 11.
4
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.
Pharmacol Rev. 2021 Oct;73(4):298-487. doi: 10.1124/pharmrev.120.000131.

本文引用的文献

1
Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators.
J Med Chem. 2014 Mar 27;57(6):2334-56. doi: 10.1021/jm401695d. Epub 2014 Feb 25.
4
Structural determinants of agonist efficacy at the glutamate binding site of N-methyl-D-aspartate receptors.
Mol Pharmacol. 2013 Jul;84(1):114-27. doi: 10.1124/mol.113.085803. Epub 2013 Apr 26.
5
Novel NMDA receptor modulators: an update.
Expert Opin Ther Pat. 2012 Nov;22(11):1337-52. doi: 10.1517/13543776.2012.728587. Epub 2012 Sep 26.
6
Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex.
Nat Protoc. 2012 Sep;7(9):1741-54. doi: 10.1038/nprot.2012.099. Epub 2012 Aug 30.
7
Structure-activity relationships for allosteric NMDA receptor inhibitors based on 2-naphthoic acid.
Neuropharmacology. 2012 Mar;62(4):1730-6. doi: 10.1016/j.neuropharm.2011.11.019. Epub 2011 Dec 6.
8
Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators.
Mol Pharmacol. 2011 Nov;80(5):782-95. doi: 10.1124/mol.111.073239. Epub 2011 Aug 1.
9
Novel N-methyl-D-aspartate receptor antagonists: a review of compounds patented since 2006.
Expert Opin Ther Pat. 2010 Dec;20(12):1683-702. doi: 10.1517/13543776.2010.533656. Epub 2010 Nov 8.
10
A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors.
Nat Commun. 2010 Oct 5;1:90. doi: 10.1038/ncomms1085.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验